Clinical Trials in Cork - 21 Active Studies

Diastolic Dysfunction, Neonatal Encephalopathy, Small for Gestational Age at Delivery, Transient Tachypnea of the Newborn
University College Cork · started 2024-02-12

📍 Cork

NCT06200519 on ClinicalTrials.gov ↗

Active

U011 - Wireless Ultra Long-Term EEG Recordings in Epilepsy

Epilepsy
UNEEG Medical A/S · started 2023-12-04

📍 Cork · Dublin

NCT05915988 on ClinicalTrials.gov ↗

Active Phase 2

Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)

HER2-positive Breast Cancer
Cancer Trials Ireland · started 2023-10-26

📍 Galway · Dublin · Cork · Limerick

NCT05710666 on ClinicalTrials.gov ↗

Active

Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

Ulcerative Colitis
Alfasigma S.p.A. · started 2023-06-12

📍 Cork · Dublin

NCT05817942 on ClinicalTrials.gov ↗

Active

Linking In With Advice and Supports for Men Impacted by Metastatic Cancer

Survivorship, Prostate Cancer, Kidney Cancer, Urothelial Tract/Bladder Cancer, Nos
University College Cork · started 2023-05-08

📍 Cork

NCT05946993 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Heart Failure
Novo Nordisk A/S · started 2023-05-08

📍 Dublin · Cork · Mahon, Cork

NCT05636176 on ClinicalTrials.gov ↗

Recruiting Phase 3

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Multiple Myeloma
European Myeloma Network B.V. · started 2022-09-08

📍 Cork · Dublin · Galway · Limerick

NCT05243797 on ClinicalTrials.gov ↗

Recruiting

30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants

Premature Infant, Respiratory Distress Syndrome in Premature Infant, Neurodevelopmental Outcome
University of Alberta · started 2022-06-27

📍 Cork

NCT03825835 on ClinicalTrials.gov ↗

Active Phase 3

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy

Muscle-invasive Bladder Cancer
Hoffmann-La Roche · started 2021-05-03

📍 Cork · Dublin

NCT04660344 on ClinicalTrials.gov ↗

Active Phase 3

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

Prostate Cancer
University of Sydney · started 2020-03-31

📍 Rathgar · Cork · Dublin · Galway

NCT04136353 on ClinicalTrials.gov ↗

Active Phase 3

Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals · started 2019-06-04

📍 Dublin · Cork · Galway

NCT03969004 on ClinicalTrials.gov ↗

Active Phase 3

A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2
Stichting Hemato-Oncologie voor Volwassenen Nederland · started 2019-03-01

📍 Cork · Dublin · Galway

NCT03839771 on ClinicalTrials.gov ↗

Active Phase 3

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

Progressive Multiple Sclerosis (PMS)
Hoffmann-La Roche · started 2018-05-28

📍 Cork · Dublin

NCT03523858 on ClinicalTrials.gov ↗

Active Phase 3

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

Crohn's Disease
AbbVie · started 2018-03-21

📍 Cork

NCT03345823 on ClinicalTrials.gov ↗

Active Phase 2

To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.

Metastatic Triple Negative Breast Cancer
AstraZeneca · started 2018-03-07

📍 Cork · Dublin

NCT03330847 on ClinicalTrials.gov ↗

No trials match your search.

Browse by location

Dublin · 68 Cork · 21 Galway · 18 Limerick · 9 Waterford · 6 Beaumont · 3 Sligo · 2 Letterkenny · 2 Mayo · 1 Mahon, Cork · 1 Castlebar · 1 Abbotstown · 1

Browse by condition

Breast Cancer · 4 Prostate Cancer · 4 Cancer · 3 Dementia · 3 Fallopian Tube Cancer · 3 Alzheimers Disease · 2 Alzheimers Disease, Familial · 2 Non Small Cell Lung Cancer · 2 Early Breast Cancer · 2 Primary Peritoneal · 2 Chronic Lymphocytic Leukemia · 2 Hypertension · 2 Vascular Diseases · 2 Cardiovascular Diseases · 2

Cite this page

Priya Life Science (2026). Clinical Trials in Ireland Tracker. Available at: https://priyalifescience.com/clinical-trials-ireland/city/cork (Accessed: 7 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Irish site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see our EU Clinical Trials Tracker.